Clinical Trials Logo

Amphetamine-related Disorders clinical trials

View clinical trials related to Amphetamine-related Disorders.

Filter by:

NCT ID: NCT06145698 Recruiting - Clinical trials for Amphetamine-Related Disorders

Treatment Effect of Cross-frequency Transcranial Alternating Current Stimulation on the MUD

Start date: October 15, 2023
Phase: N/A
Study type: Interventional

The purpose of this research is to evaluate the efficacy of multiple sessions of theta-gamma cross-frequency transcranial alternating current stimulation in patients with methamphetamine (MA) use disorders.

NCT ID: NCT05535101 Not yet recruiting - Depression, Anxiety Clinical Trials

Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The study aims to apply the intermittent theta burst transcranial magnetic stimulation (iTBS) treatment and evaluate the effect in improving craving, affective symptoms, and cognitive function for those participants in the community with amphetamine use. An electroencephalography and blood biomarkers will also be examined to explore the possible mechanisms.

NCT ID: NCT05515757 Enrolling by invitation - Clinical trials for Amphetamine-Related Disorders

Hospital-Based Contingency Management

Start date: August 22, 2022
Phase: N/A
Study type: Interventional

This study aims to adapt an outpatient mobile app-based contingency management intervention to the hospital setting to understand how we can use contingency management to improve health outcomes in hospitalized patients with stimulant use disorders.

NCT ID: NCT04993300 Completed - Depression, Anxiety Clinical Trials

Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction

Start date: February 17, 2022
Phase: N/A
Study type: Interventional

The study aims to test whether transcranial magnetic stimulation (TMS) improves the craving, depression, anxiety and cognitive function during the abstinent period of methamphetamine users.

NCT ID: NCT04982796 Recruiting - Clinical trials for Amphetamine-Related Disorders

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

Start date: July 7, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This is a proof-of-concept randomized clinical trial of psilocybin-enhanced psychotherapy versus treatment-as-usual among individuals being treated for methamphetamine use disorder.

NCT ID: NCT04687566 Recruiting - Clinical trials for Amphetamine Addiction

Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction

Start date: August 11, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators will conducted a randomized double-blind placebo-controlled study to investigate the treatment outcomes of add-on low dose dextromethorphan (DM), memantine (MM), or dextromethorphan and memantine combination (DM+MM) in amphetamine-type stimulants use disorder patients.

NCT ID: NCT04531384 Recruiting - Clinical trials for Amphetamine Addiction

Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this research is to evaluate the efficacy and safety of Robot-assisted rehabilitation intelligent system as a virtual stand-alone treatment, delivered with minimal clinical monitoring compared with treatment as usual in methamphetamine (MA) use disorders.

NCT ID: NCT04203654 Recruiting - Clinical trials for Amphetamine-Related Disorders

Implementation and Effectiveness of Multidiscipline-Integrated Addiction Treatment Model

Start date: February 24, 2020
Phase: N/A
Study type: Interventional

Management of substance use disorders in clinical settings is challenging. Approaches with integrated bio-psycho-social interventions, along with the engagement of families and self-help groups are strongly recommended. The Matrix intensive outpatient program has been developed in UCLA to help the psychostimulant misusers in the Southern California in 1980's. With integration of the existing evidence of addiction researches and empirically supported cognitive-behavior treatment techniques, the Matrix model developed manuals to address knowledge and skills needed for drug users in their early recovery and relapse prevention. The treatment was delivered in a 16-week intensive structured group sessions. There was also a 12-week educational sessions for the in-treatment individuals and their families. A substantial body of evidence has demonstrated the successful experience of the Matrix treatment model in management a broad spectrum of addictive disorders in many countries. The objectives of the pilot project are to set up a multi-center collaborative clinical network with implementation of an integrated addiction treatment program modified from the UCLA Matrix model. Via the establishment of standardized subject recruitment criteria, treatment and outcome assessment procedures, the study aims to assess the adherence of participating clinical organizations to the study protocol, the acceptance of participating MA misusers for the integrated treatment program as well as the outcomes and their determinants for the treatment models.

NCT ID: NCT03902405 Recruiting - Clinical trials for Substance-Related Disorders

Computerized Exercise to Alter Stimulant Approach Responses

CEASAR
Start date: June 11, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the Computerized Exercise to Alter Stimulant Approach Responses (CEASAR), a novel stimulant use cessation intervention, for clients currently enrolled in a treatment centre for mental health and addiction. The investigators plan to conduct a randomized, single-blind controlled trial involving inpatients presenting with concurrent disorders to test the impact of this novel computerized intervention. This pilot study will be conducted at the Burnaby Centre for Mental Health and Addiction (BCMHA) in Burnaby, BC, Canada.

NCT ID: NCT03318081 Completed - Clinical trials for Amphetamine Addiction

The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction

Start date: October 20, 2017
Phase: N/A
Study type: Interventional

The computerized cognitive rehabilitation therapy will be used to treat amphetamine-type stimulant (ATS) addiction.